✦ LIBER ✦

Improving the availability and accessibility of opioids for the treatment of pain: The International Pain Policy Fellowship

✍ Scribed by Snezana Bosnjak; Martha A. Maurer; Karen M. Ryan; Marta X. Leon; Gabriel Madiye

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 277 KB
Volume: 19
Category: Article
ISSN: 0941-4355
DOI: 10.1007/s00520-011-1200-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Pain Cycle: Implications for the Dia

The Pain Cycle: Implications for the Diagnosis and Treatment of Pelvic Pain Syndromes

✍ K. Everaert; J. Devulder; M. De Muynck; S. Stockman; H. Depaepe; D. De Looze; J. 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 103 KB

Milnacipran for the treatment of chronic

Milnacipran for the treatment of chronic pain

✍ Mitsuhiro Kamata; Shingo Naito; Hitoshi Takahashi; Hisashi Higuchi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 34 KB

Fluoxetine for the treatment of neuropat

Fluoxetine for the treatment of neuropathic pain

✍ Abdula, A ;Burden, A C 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Design and synthesis of trivalent ligand

Design and synthesis of trivalent ligands targeting opioid, cholecystokinin, and melanocortin receptors for the treatment of pain

✍ Yeon Sun Lee; Steve Fernandes; Vinod Kulkarani; Alexander Mayorov; Peg Davis; Sh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 511 KB

It has been known that co-administration of morphine with either cholecystokinin (CCK) receptor or melanocortin (MC) receptor antagonists enhance morphine's analgesic efficacy by reducing serious side effects such as tolerance and addiction. Considering these synergistic effects, we have designed t

Buscopan® for the treatment of pain afte

Buscopan® for the treatment of pain after laparoscopic sterilisation

✍ A. Habib; P. Sharpe; S. Anderson; S. Francis; A. C. Davidson; G. Smith 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB

Critical incident monitoring has the advantage of identifying a potential risk to the patient without it necessarily resulting in morbidity. An added advantage in developing countries is the low cost involved in introducing the programme. This paper analyses the incidents reported from the operating

Fentanyl buccal tablet for the treatment

Fentanyl buccal tablet for the treatment of breakthrough pain in opioid-tolerant patients with chronic cancer pain : A long-term, open-label safety study

✍ Sharon M. Weinstein; John Messina; Fang Xie 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB 👁 2 views